相关实验视频
Updated: Sep 18, 2025

10:02
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
Published on: July 23, 2016
32.5K
嵌入甲载纳米颗粒的可溶性微针的安全性和有效性,用于治疗眼部炎症
Rawan Fitaihi1, Aws Alshamsan2, Shorooq Abokhamees3
1Research Department of Pharmaceutics, School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK; Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia(1).
International journal of pharmaceutics
|June 24, 2025
概括
这项研究表明,装有德甲 (Dex) 的可溶性微针 (MNs) 对于治疗眼睛炎症是安全有效的. 在子模型中,Dex-MN系统成功地减少了脑膜炎症状和炎症标志物.
科学领域:
- 眼科医生 眼科 眼科
- 纳米技术纳米技术
- 药理学 药理学是指药理学的学科.
背景情况:
- 微针 (MN) 系统显示了将药物输送到眼部组织的潜力.
- 之前的研究表明,PLGA微粒通过MNs向质组织输送.
研究的目的:
- 为了评估装有德克萨 (Dex) 纳米粒子的可溶性微针 (MN) 系统的眼睛毒性和治疗效果.
- 评估Dex-loaded MNs在内毒素诱导的卵膜炎的子模型中的安全性和有效性.
主要方法:
- 使用内毒素诱导性脑膜炎的子模型进行体内研究.
- 评估Blank-MN和Dex-MN贴片对眼睛的毒性,刺激和治疗活性.
- 测量促炎和亡标志物 (TNF-α,IL-6,MPO,Bax,BCL2,NF-κB,Caspase3) 的测量结果.
- 眼睛组织的组织病理学评估.
主要成果:
- 无论是Blank-MN还是Dex-MN贴片,都会对眼睛产生最小的刺激,没有机械损伤.
- 与Blank-MN贴片相比,Dex-MN贴片的刺激分数较低,恢复速度更快.
- 德克斯-MN治疗显著降低了临床脑膜炎得分和炎症标志物.
- 组织病理学证实Dex-MN治疗眼睛的炎症和细胞透减少.
结论:
- 装有德克萨米他纳米颗粒的可溶性微针系统是用于眼部药物输送的安全有效平台.
- 这种Dex-MN系统为治疗眼部炎症提供了显著的治疗益处.
- 微针技术为非侵入性眼部药物输送提供了一个有前途的方法.
相关概念视频
Drug Delivery: Miscellaneous Routes
473
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
473
Factors Affecting Dissolution: Particle Size and Effective Surface Area
1.0K
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
1.0K

